Latest news
BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline - Yahoo! Finance CanadaYahoo! Finance Canada · Tue, 04 Aug 2026 07:05:00 GMTAI joins the quest to find new treatments for rare neuromuscular diseases - Innovation News NetworkInnovation News Network · Wed, 29 Jul 2026 08:34:14 GMT